Anti-GSK3 beta (phospho S9) antibody [EPR2286Y] (Ab75814)
Glycogen synthase kinase-3 beta, GSK-3 beta, Serine/threonine-protein kinase GSK3B, GSK3B
详细信息
背景信息
What is this antibody validated in? Anti-GSK3 beta (phospho S9) antibody [EPR2286Y] (ab75814) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF), Dot Blot in Human samples. What is the molecular weight of GSK3 beta? Anti-GSK3 beta (phospho S9) [EPR2286Y] (ab75814) specifically detects a band for GSK3 beta (UniProt: P49841) at a molecular weight of 47kDa. Trusted by the scientific community Anti-GSK3 beta (phospho S9) [EPR2286Y] (ab75814) was first used in a scientific publication in 2009 and has been cited over 110 times in peer-reviewed journals. Reviewed by scientists Anti-GSK3 beta (phospho S9) [EPR2286Y] (ab75814) has over 5 independent reviews from customers. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Other related products We have a range of other formats of antibody clone [EPR2286Y] also available for your convenience: ab75814, Carrier free - ab219359 Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (128)
Evaluation of Therapeutic Effects and Underlying Mechanisms of Baichuan Baile Formula in Rodent Insomnia Models.
评价百川百乐方在啮齿动物失眠模型中的治疗效果及其潜在机制。
Glucocorticoid-Induced alterations in DNA methylation in the H19 promoter of Bone Marrow-Derived Mesenchymal Stem Cells are associated with the pathogenesis of osteonecrosis.
骨髓间充质干细胞 H19 启动子中糖皮质激素诱导的 DNA 甲基化改变与骨坏死的发病机制有关。
Aerosolized nicotine-free e-liquid base constituents exacerbates mitochondrial dysfunction and endothelial glycocalyx shedding via the AKT/GSK3β-mPTP pathway in lung injury models
雾化无尼古丁电子液体基础成分通过 AKT/GSK3β-mPTP 通路加剧肺损伤模型中的线粒体功能障碍和内皮糖萼脱落
Electroacupuncture ameliorates cognitive dysfunction in T2DM rats by modulating astrocytic polarization and aberrant energy metabolism in the hippocampus via the Wnt/β-catenin pathway.
电针疗法通过 Wnt/β-catenin 通路调节海马星形胶质细胞极化和异常能量代谢,从而改善 2 型糖尿病大鼠的认知功能障碍
Canagliflozin alleviates acetaminophen-induced renal and hepatic injury in mice by modulating the p-GSK3β/Fyn-kinase/Nrf-2 and p-AMPK-α/STAT-3/SOCS-3 pathways
卡格列净通过调节 p-GSK3β/Fyn-kinase/Nrf-2 和 p-AMPK-α/STAT-3/SOCS-3 通路减轻对乙酰氨基酚引起的小鼠肾脏和肝脏损伤
AHNAK2 confers 5-fluorouracil resistance in colorectal cancer via activation of the AKT/GSK-3β signaling axis.
AHNAK2 通过激活 AKT/GSK-3β 信号轴赋予结直肠癌 5-氟尿嘧啶耐药性
Peiminine suppresses prostate cancer progression by regulating cell proliferation, motility, apoptosis, and mitochondrial dysfunction.
培米宁通过调节细胞增殖、运动、凋亡和线粒体功能障碍来抑制前列腺癌的进展。
ALPP Induces Epithelial-Mesenchymal Transition by Activating the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer Cells.
ALPP通过激活结直肠癌细胞中的Wnt/β-catenin信号通路诱导上皮-间质转化。
Neuropilin-2 Mediates Radioresistance in Nasopharyngeal Carcinoma via Wnt/β-Catenin Pathway.
Neuropilin-2 通过 Wnt/β-catenin 通路介导鼻咽癌的放射抗性。
The Effect of Nerve Growth Factor on Cartilage Fibrosis and Hypertrophy during In Vitro Chondrogenesis Using Induced Pluripotent Stem Cells
神经生长因子对诱导性多能干细胞体外软骨形成过程中软骨纤维化和肥大的影响
- 1
- 2
- 3
- 4
- 5
- 6
- 13